$11.06
0.075[0.68%]
At close: Apr 26
$11.06
0[0.00%]
After Hours: 4:00PM EDT
Zentalis Pharma
(NASDAQ:ZNTL)Latest News for Zentalis Pharma Stock (NASDAQ:ZNTL)
Zentalis Pharma Stock (NASDAQ: ZNTL)
Categories: All
Thursday, April 11, 2024
Thursday, March 28, 2024
Wednesday, February 28, 2024
- HC Wainwright & Co. Reiterates Buy on Zentalis Pharma, Maintains $46 Price TargetBenzinga Newsdesk - Feb 28, 2024, 12:50PM
- Zentalis Pharmaceuticals shares are trading higher after Wedbush maintained a Neutral rating on the stock and raised its price target from $12 to $15.Benzinga Newsdesk - Feb 28, 2024, 11:07AM
- Wedbush Maintains Neutral on Zentalis Pharma, Raises Price Target to $15Benzinga Newsdesk - Feb 28, 2024, 8:02AM
Tuesday, February 27, 2024
Monday, January 08, 2024
Tuesday, November 14, 2023
Wednesday, November 08, 2023
Tuesday, November 07, 2023
- Analyst Expectations for Zentalis Pharma's FutureBenzinga Insights - Nov 7, 2023, 12:00PM
- Morgan Stanley Maintains Overweight Rating for Zentalis Pharma: Here's What You Need To KnowBenzinga Insights - Nov 7, 2023, 12:00PM
- Stifel Maintains Buy on Zentalis Pharma, Lowers Price Target to $36Benzinga Newsdesk - Nov 7, 2023, 10:16AM
- Morgan Stanley Maintains Overweight on Zentalis Pharma, Lowers Price Target to $38Benzinga Newsdesk - Nov 7, 2023, 9:18AM
- HC Wainwright & Co. Maintains Buy on Zentalis Pharma, Lowers Price Target to $46Benzinga Newsdesk - Nov 7, 2023, 8:18AM
Monday, November 06, 2023
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Nov 6, 2023, 12:31PM
- Zentalis Pharmaceuticals shares are trading lower. The company reported Q3 financial results.Benzinga Newsdesk - Nov 6, 2023, 10:54AM
- TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On MondayLisa Levin - Nov 6, 2023, 10:27AM
- Zentalis Pharma Q3 EPS $(0.79) Vs $(0.96) Prior YearBenzinga Newsdesk - Nov 6, 2023, 7:22AM
Tuesday, October 10, 2023
Thursday, August 10, 2023
- Where Zentalis Pharma Stands With AnalystsBenzinga Insights - Aug 10, 2023, 11:00AM
- Wells Fargo Maintains Overweight on Zentalis Pharma, Lowers Price Target to $50Benzinga Newsdesk - Aug 10, 2023, 10:05AM
- Wedbush Reiterates Outperform on Zentalis Pharma, Maintains $38 Price TargetBenzinga Newsdesk - Aug 10, 2023, 9:41AM
- HC Wainwright & Co. Reiterates Buy on Zentalis Pharma, Maintains $55 Price TargetBenzinga Newsdesk - Aug 10, 2023, 6:40AM
Wednesday, August 09, 2023
Wednesday, June 21, 2023
Thursday, June 15, 2023
- 5 Short Squeeze Stocks In Play Thursday: Nikola, Verve, Carvana, MorePiero Cingari - Jun 15, 2023, 3:41PM
- Zentalis Pharmaceuticals shares are trading higher after the company announced it regained worldwide development and commercialziation rights to azenosertib , ZN-d5 and ZN-c5 in Greater China.Benzinga Newsdesk - Jun 15, 2023, 2:39PM
- Domino's Pizza, Patterson-UTI Energy, JinkoSolar And Other Big Stocks Moving Higher On ThursdayLisa Levin - Jun 15, 2023, 10:43AM
- Zentalis Regains Worldwide Development and Commercialization Rights to Azenosertib, ZN-d5 and ZN-c5 As a Result of Termination of Greater China Collaboration and License AgreementsCharles Gross - Jun 15, 2023, 6:28AM
- Zentalis Pharmaceuticals Reports Pricing Of Offering Of 11.03M Shares At $22.66 Per Share For Total Gross Proceeds Of $250MBenzinga Newsdesk - Jun 15, 2023, 6:06AM
Wednesday, June 07, 2023
- Analyst Expectations for Zentalis Pharma's FutureBenzinga Insights - Jun 7, 2023, 11:01AM
- Wedbush Reiterates Outperform on Zentalis Pharma, Maintains $38 Price TargetBenzinga Newsdesk - Jun 7, 2023, 8:16AM
- Stifel Maintains Buy on Zentalis Pharma, Raises Price Target to $50Benzinga Newsdesk - Jun 7, 2023, 7:58AM
Friday, May 26, 2023
- Oppenheimer Reiterates Outperform on Zentalis Pharma, Maintains $50 Price TargetBenzinga Newsdesk - May 26, 2023, 11:08AM
- Wedbush Maintains Outperform on Zentalis Pharma, Raises Price Target to $38Benzinga Newsdesk - May 26, 2023, 9:18AM
- Zentalis Gears Up for Phase 3 Study of Azenosertib after Positive Phase 1b OutcomesVandana Singh - May 26, 2023, 8:53AM
- HC Wainwright & Co. Reiterates Buy on Zentalis Pharma, Maintains $55 Price TargetBenzinga Newsdesk - May 26, 2023, 6:07AM
Friday, May 19, 2023
Thursday, May 11, 2023
- Zentalis Pharmaceuticals shares are trading higher on continued upward momentum after the company yesterday reported Q1 financial results.Benzinga Newsdesk - May 11, 2023, 3:02PM
- HC Wainwright & Co. Reiterates Buy on Zentalis Pharma, Maintains $55 Price TargetBenzinga Newsdesk - May 11, 2023, 1:07PM
- Oppenheimer Reiterates Outperform on Zentalis Pharma, Maintains $50 Price TargetBenzinga Newsdesk - May 11, 2023, 10:59AM